Bradley Foster & Sargent Inc Boston Scientific Corp Transaction History

Bradley Foster & Sargent Inc

$5.82 Billion
Q3 2024

A detailed history of Bradley Foster & Sargent Inc transactions in Boston Scientific Corp stock. As of the latest transaction made, Bradley Foster & Sargent Inc holds 586,208 shares of BSX stock, worth $53.4 Million. This represents 0.84% of its overall portfolio holdings.

Number of Shares

586,208

Previous 668,396 12.3%

Holding current value

$53.4 Million

Previous $51.5 Million 4.56%

% of portfolio

0.84%

Previous 0.94%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$72.96 - $84.0 $6 Million - $6.9 Million	-82,188 Reduced 12.3%	586,208 $49.1 Million
Q2 2024 Aug 09, 2024	SELL	$67.33 - $77.71 $285,075 - $329,024	-4,234 Reduced 0.63%	668,396 $51.5 Million
Q1 2024 May 15, 2024	SELL	$57.6 - $68.62 $136,281 - $162,354	-2,366 Reduced 0.35%	672,630 $46.1 Million
Q4 2023 Feb 14, 2024	BUY	$48.64 - $57.81 $764,523 - $908,657	15,718 Added 2.38%	674,996 $39 Million
Q2 2023 Aug 08, 2023	SELL	$49.72 - $54.64 $9.14 Million - $10 Million	-183,886 Reduced 21.81%	659,278 $35.7 Million
Q1 2023 May 08, 2023	BUY	$45.09 - $50.03 $213,816 - $237,242	4,742 Added 0.57%	843,164 $42.2 Million
Q4 2022 Feb 14, 2023	BUY	$39.56 - $47.22 $100,838 - $120,363	2,549 Added 0.3%	838,422 $38.8 Million
Q3 2022 Nov 14, 2022	BUY	$36.71 - $109.66 $190,084 - $567,819	5,178 Added 0.62%	835,873 $32.4 Million
Q2 2022 Aug 11, 2022	SELL	$35.24 - $47.1 $300,209 - $401,244	-8,519 Reduced 1.02%	830,695 $31 Million
Q1 2022 May 16, 2022	BUY	$40.9 - $45.1 $34.3 Million - $37.8 Million	839,214 New	839,214 $37.2 Million

Others Institutions Holding BSX

# of Institutions

1,542

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $130B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bradley Foster & Sargent Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bradley Foster & Sargent Inc with notifications on news.

Account

Bradley Foster & Sargent Inc Boston Scientific Corp Transaction History